BeiGene, Ltd(NASDAQ:BGNE) 
BeiGene, Ltd., a commercial-stage biotechnology company, engages in discovering, developing, manufacturing, and commercializing medicines for cancer therapeutics in the People's Republic of China and the United States. Its commercial products include BRUKINSA to treat relapsed/refractory (R/R) mantl...
Website: http://www.beigene.com
Founded: 2010
Full Time Employees: 9,400 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-05
P
O 149.00
H 149.00
L 145.53
C 147.04
V 88,432
10EMA 147.04
20EMA 147.04
60EMA 147.04
120EMA 147.04
250EMA 147.04